Oncovin Liquid, sol inj 1 mg/ml i.v. , flac 1 ml
7680453230136
CH-45323
L01CA02
Reimbursement limitations:
ONCOVIN
Sont remboursés
- le traitement de la leucémie aiguë;
- le traitement combiné de …
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.2 MG | Substance | HBESI |
|
(N/A)
|
1.3 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.007 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 30.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1984
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 45323
- Drug name
- Oncovin Liquid, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- L01CA02
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- A
- First authorization
- 01/06/1983
- Authorization expiration date
- 28/02/2025
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ONCOVIN Liquid sol inj 1 mg/ml i.v. flac 1 ml
- Description (DE)
- ONCOVIN Liquid Inj Lös 1 mg/ml i.v. Durchstf 1 ml
- Market withdrawal
- 28/02/2025
- Narcotic (BTM)
- No